Projects per year
Personal profile
Expertise
- Basic and translational research in multiple myeloma
- Research for therapies, targeting the myeloma cell in its microenvironment
- Study of functional interaction between the cancer cell and its microenvironment using microarray, realtime PCR and FACS analysis and westernblotting.
- Investigate the influence of histon deacetylase inhibitors (HDAC-I) in 5TMM models.
Fingerprint
Dive into the research topics where Karin Vanderkerken is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
BASGO38: OZR Basisfinanciering voor Grote Onderzoeksgroepen - TORC
1/01/24 → 31/12/29
Project: Fundamental
-
SRP84: SRP-Onderzoekszwaartepunt: PACT: multi-omics Profiling of T cells to improve Adoptive Cell Therapy
Vanderkerken, K., Breckpot, K. & Menu, E.
1/11/22 → 31/10/27
Project: Fundamental
-
FWOAL1045: Nanobody-based AXL targeting and combination treatment for acute myeloid leukemia and multiple myeloma
De Veirman, K., Devoogdt, N. & Vanderkerken, K.
1/01/22 → 31/12/25
Project: Fundamental
-
AIIFUND22: A new strategy in eradicating residual cancer cells in multiple myeloma.
Vanderkerken, K. & De Veirman, K.
28/09/17 → …
Project: Fundamental
Research output
-
Correction to: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma (Journal of Hematology & Oncology, (2024), 17, 1, (128), 10.1186/s13045-024-01636-4)
Hose, D., Ray, S., Rößler, S., Thormann, U., Schnettler, R., de Veirman, K., Khassawna, T. E., Heiss, C., Hild, A., Zahner, D., Alagboso, F., Henss, A., Beck, S., Emde-Rajaratnam, M., Burhenne, J., Bamberger, J., Menu, E., de Bruyne, E., Gelinsky, M., Kampschulte, M. & 6 others, , 24 Jan 2025, In: Journal of Hematology & Oncology. 18, 1, 1 p., 11.Research output: Contribution to journal › Comment/debate
Open Access -
Targeting MAT2A alters the methylation landscape and DNA damage response in Multiple Myeloma, revealing novel combination strategies.
Van Hemelrijck, L. A., Wang, Y., Muylaert, C., Olsen, C., De Veirman, K., Vanderkerken, K., Menu, E. & De Bruyne, E., 7 Feb 2025. 1 p.Research output: Unpublished contribution to conference › Poster
-
Activated cDCs by anti-CD40 agonist therapy induce anti-tumor effectsin Multiple Myeloma
Verheye, E., Kancheva, D., Satilmis, H., Vandewalle, N., Fan, R., Bardet, P., Clappaert, E., Vanderkerken, K., De Veirman, K. & Laoui, D., 2024, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 1 Feb 2024, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
Adrenergic signaling activates the tumor immune microenvironment in Multiple Myeloma
Satilmis, H., Verheye, E., Vandewalle, N., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 30 May 2024, (Unpublished).Research output: Unpublished contribution to conference › Poster
Datasets
-
A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages
Laoui, D. (Creator), Kancheva, D. (Creator), Satilmis, H. (Creator), Vandewalle, N. (Creator), Fan, R. (Creator), Bardet, P. (Creator), Clappaert, E. (Creator), Verstaen, K. (Creator), De Becker, A. (Creator), Vanderkerken, K. (Creator) & De Veirman, K. (Creator), NCBI Gene Expression Omnibus, 14 Nov 2024
Dataset
Prizes
-
Award of the Association for International Cancer Research
Vanderkerken, Karin (Recipient), 2004
Prize: Prize (including medals and awards)
-
Best Poster Presentation BHS 2025
Van Hemelrijck, Lien Ann (Recipient), Wang, Yanmeng (Recipient), Muylaert, Catharina (Recipient), Olsen, Catharina (Recipient), De Veirman, Kim (Recipient), Vanderkerken, Karin (Recipient), Menu, Eline (Recipient) & De Bruyne, Elke (Recipient), 7 Feb 2025
Prize: Prize (including medals and awards)
-
Hilde Bruers Award
Vanderkerken, Karin (Recipient), 29 Feb 2008
Prize: Prize (including medals and awards)
-
Junior Award Multiple Myeloma Research Foundation
Vanderkerken, Karin (Recipient), 2001
Prize: Prize (including medals and awards)
-
Laureaat Belgische Federatie tegen Kanker
Vanderkerken, Karin (Recipient), 2001
Prize: Prize (including medals and awards)
Activities
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Niels Vandewalle (Presenter), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Yanmeng Wang (Contributor), Timo De Groof (Contributor), Nathan De Beule (Contributor), Tessa kerre (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
12 Mar 2024Activity: Talk or presentation › Talk or presentation at a conference
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Mapping the immune heterogeneity within the myeloma microenvironment using single-cell transcriptomics
Emma Verheye (Speaker), Rong Fan (Contributor), Hatice Satilmis (Contributor), Niels Vandewalle (Contributor), Pauline Bardet (Contributor), Emile Clappaert (Contributor), Daliya Kancheva (Contributor), Elke De Bruyne (Contributor), Karin Vanderkerken (Contributor), Kim De Veirman (Contributor) & Damya Laoui (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
Lien De Beck (Speaker), Robin Maximilian Awad (Contributor), Yannick De Vlaeminck (Contributor), Veronica Basso (Contributor), Noelia Casares (Contributor), Stefaan Verhulst (Contributor), Edurne San José-Enériz (Contributor), Kirsten De Ridder (Contributor), Cleo Goyvaerts (Contributor), Ken Maes (Contributor), Karin Vanderkerken (Contributor), Xabier Agirre (Contributor), Filipe Prosper (Contributor), Juan José Lasarte (Contributor), Anna Mondino (Contributor) & Karine Breckpot (Contributor)
11 Feb 2021Activity: Talk or presentation › Talk or presentation at a conference
-
Lunchdebat Gelijkheidsactieplan
Gina Rossi (Participant) & Karin Vanderkerken (Participant)
19 Nov 2019Activity: Other